Gut microbiome-targeted therapies in liver cirrhosis: a protocol for systematic review and meta-analysis

BACKGROUND: Microbiome-targeted therapies (MTTs), including probiotics, prebiotics, synbiotics, and fecal microbiota transplantation (FMT), have been proposed as a potential treatment for cirrhosis via modulation of gut microbiome, while the impact of gut microflora alteration on liver function in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Honglin, Peng, Yan, Zhang, Wei, Chen, Yue, Jiang, Qingwu, Zhou, Yibiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429623/
https://www.ncbi.nlm.nih.gov/pubmed/36042459
http://dx.doi.org/10.1186/s13643-022-02059-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429623/
https://www.ncbi.nlm.nih.gov/pubmed/36042459
http://dx.doi.org/10.1186/s13643-022-02059-3

Ejemplares similares